Wolf Greenfield and Client Cold Spring Harbor Laboratory Prevail in 4 IPRs
Wolf Greenfield recently convinced the U.S. Patent Trial and Appeal Board not to institute four inter partes reviews (IPRs) on four separate patents, on behalf of the firm’s longtime client, Cold Spring Harbor Laboratory.
Impact of Post-Grant Proceedings on Biologics and Biosimilars
This article discusses strategic considerations for the use of post-grant proceedings to try to bring greater certainty to biosimilar development, including analysis of IPRs that have been filed to date.
You received this email because you are subscribed to Newsletter from Wolf, Greenfield & Sacks, P.C.. If you prefer not to receive emails from Wolf, Greenfield & Sacks, P.C. you may unsubscribe or set your email preferences.